JenaValve
1 known investors
JenaValve manufactures the Trilogy Transcatheter Heart Valve System, an FDA-approved device for treating severe aortic regurgitation in high-risk patients who cannot undergo surgical valve replacement. The company develops minimally invasive cardiac medical devices and related delivery systems for interventional cardiology.
Medical Devices